Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
13.02
+2.39 (22.48%)
At close: May 5, 2026, 4:00 PM EDT
13.30
+0.28 (2.15%)
After-hours: May 5, 2026, 7:56 PM EDT

Medifast Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Net Income
-2.12-18.12-2.262.48-0.770.81.13-8.158.326.0423.1330.2839.9726.5236.1639.1141.7834.0241.9846.96
Depreciation & Amortization
3.483.473.454.053.283.193.193.073.263.353.413.372.972.952.852.732.44-0.461.311.33
Stock-Based Compensation
1.92.170.912.631.932.130.612.452.172.392.682.510.612.952.962.872.283.292.272.15
Other Adjustments
-1.0813.480.95-1.520.74-6.192.9710.84-1.48.01-5.281.762.174.31-0.221.61.63-2.141.341.32
Changes in Inventories
-1.182.9879.163.06-2.33-0.496.678.323.6410.672821.9626.4211.732-8.93-50.43-33.82-33.56
Changes in Accounts Payable
-1.45-4.3-0.52-13.1-6-11.22-4.35-3.51-15.92-0.36-3.49-9.95-21.9-15.34-8.34-20.97-6.0811.635.797.76
Changes in Income Taxes Payable
-0.2-0.820.21-7.141.149.710.5-3.263.26-10.14-2.891.9412.60.588.4-21.6814.08---
Changes in Other Operating Activities
0.91-4.132.370.250.03-1.055.51-0.88-0.72-2.41.7-4.15.683.341.89-5.02-3.53-5.94-3.07-4.59
Operating Cash Flow
0.26-5.2812.11-3.383.41-4.959.0713.077.2810.5229.9343.1564.0651.7455.443.7643.67-7.4615.820.88
Operating Cash Flow Growth
-92.37%-33.52%--53.23%--69.69%-69.71%-88.63%-79.66%-45.97%-1.41%46.68%-250.61%109.61%-33.15%--61.57%-63.70%
Capital Expenditures
-1.1-1.35-1.36-1.38-1.52-2.29-1.39-1.94-1.84-0.95-1.68-1.74-2.12-9.06-1.77-2.84-3.01-11.62-10.39-7.6
Sale of Property, Plant & Equipment
3.64-------------------
Purchases of Investments
-49.32-32.91-20.43-16.07-14.99-22.24-6.71-8.48-9.17-9.79-44.78---------
Proceeds from Sale of Investments
29.6529.317.5230.8114.465.16.317.888.245.190--004.021.25001.43
Investing Cash Flow
-17.13-4.95-14.2813.36-2.05-19.43-1.78-2.53-2.78-10.73-46.46-1.74-2.12-9.06-1.771.18-1.76-11.62-10.39-6.17
Short-Term Debt Issued
---------------13.5----
Net Short-Term Debt Issued (Repaid)
---------------13.5----
Issuance of Common Stock
-----0000.040.08000.11----00.110.22
Repurchase of Common Stock
-0.8100-0-0.37-0-0-0.02-0.82-0.01-0.11-0-6.84-6.41-20.04-90.06-11.46-14.22-26.3-12.26
Net Common Stock Issued (Repurchased)
-0.8100-0-0.37-0-0-0.02-0.780.07-0.11-0-6.73-6.41-20.04-90.06-11.46-14.22-26.2-12.04
Common Dividends Paid
-0.0900-0-0.190-0-0-0.71-17.98-18.04-17.83-19.16-17.92-18.08-18.96-16.66-17.01-16.75-16.7
Financing Cash Flow
-0.900-0-0.56-0-0-0.02-1.49-17.91-18.15-17.84-25.9-24.33-45.11-102.03-28.12-31.23-42.95-28.74
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-00--000.030.02-0.20.030.090.01-0.360.120.150.03-0.020.06-0.01
Net Cash Flow
-17.77-10.22-2.179.980.79-24.387.2910.553.03-18.31-34.6523.6636.0617.988.64-56.9313.82-50.33-37.47-14.04
Free Cash Flow
-0.84-6.6310.75-4.761.88-7.237.6811.135.449.5828.2541.461.9442.6853.6340.9240.66-19.085.4113.28
Free Cash Flow Growth
--39.94%--65.37%--72.81%-73.11%-91.22%-77.56%-47.32%1.17%52.33%-891.09%208.15%-33.04%--85.70%-76.80%
FCF Margin
-1.10%-8.83%12.02%-4.51%1.63%-6.08%5.48%6.60%3.11%5.01%11.98%13.98%17.75%12.65%13.74%9.03%9.74%-5.05%1.31%3.37%
Free Cash Flow Per Share
-0.08-0.600.98-0.430.17-0.660.701.020.500.882.583.795.683.884.863.583.49-1.630.461.12
Levered Free Cash Flow
-1.65-22.288.89-5.68-0.78-3.184.11-8.014.67-0.8330.8547.7959.1735.4250.8836.8336.76-22.81.810.31
Unlevered Free Cash Flow
-3.13-26.317.68-9.081.84-3.534.49-5.882.06-1.5229.9547.4759.3135.5751.0923.4636.84-22.741.7810.38
Updated May 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q